244 related articles for article (PubMed ID: 24645697)
21. Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer.
Morgenroth A; Tinkir E; Vogg ATJ; Sankaranarayanan RA; Baazaoui F; Mottaghy FM
Breast Cancer Res; 2019 Oct; 21(1):116. PubMed ID: 31640747
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
[TBL] [Abstract][Full Text] [Related]
23. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.
Chang SS; Reuter VE; Heston WD; Gaudin PB
Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343
[TBL] [Abstract][Full Text] [Related]
24. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
25. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
Plate KH; Breier G; Farrell CL; Risau W
Lab Invest; 1992 Oct; 67(4):529-34. PubMed ID: 1434531
[TBL] [Abstract][Full Text] [Related]
27.
Akgun E; Akgun MY; Selçuk HH; Uzan M; Sayman HB
Eur J Radiol; 2020 Sep; 130():109199. PubMed ID: 32763474
[TBL] [Abstract][Full Text] [Related]
28. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.
Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV
Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135
[TBL] [Abstract][Full Text] [Related]
29. Microvascular proliferation of brain metastases mimics glioblastomas in squash cytology.
Gi T; Sato Y; Tokumitsu T; Yamashita A; Moriguchi-Goto S; Takeshima H; Sato S; Asada Y
Cytopathology; 2017 Jun; 28(3):228-234. PubMed ID: 27995658
[TBL] [Abstract][Full Text] [Related]
30. Determining the relationship between "microvessel density" and different grades of astrocytoma based on immunohistochemistry for "factor VIII-related antigen" (von Willebrand factor) expression in tumor microvessels.
Mahzouni P; Mohammadizadeh F; Mougouei K; Moghaddam NA; Chehrei A; Mesbah A
Indian J Pathol Microbiol; 2010; 53(4):605-10. PubMed ID: 21045378
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.
Huang X; Bennett M; Thorpe PE
Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of
Yadav MP; Ballal S; Sahoo RK; Tripathi M; Seth A; Bal C
Theranostics; 2020; 10(20):9364-9377. PubMed ID: 32802197
[No Abstract] [Full Text] [Related]
33. Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.
Bertagna F; Albano D; Cerudelli E; Gazzilli M; Giubbini R; Treglia G
Curr Radiopharm; 2020; 13(2):94-98. PubMed ID: 31625482
[TBL] [Abstract][Full Text] [Related]
34. The spectrum of microvascular patterns in adult diffuse glioma and their correlation with tumor grade.
Soni ; Walke V; Joshi D; Sharma T; Shrivastava A; Agrawal A
J Pathol Transl Med; 2024 May; 58(3):127-133. PubMed ID: 38766738
[TBL] [Abstract][Full Text] [Related]
35. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878
[TBL] [Abstract][Full Text] [Related]
36. Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.
Salas Fragomeni RA; Menke JR; Holdhoff M; Ferrigno C; Laterra JJ; Solnes LB; Javadi MS; Szabo Z; Pomper MG; Rowe SP
Clin Nucl Med; 2017 Oct; 42(10):e433-e435. PubMed ID: 28737579
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.
Sweat SD; Pacelli A; Murphy GP; Bostwick DG
Urology; 1998 Oct; 52(4):637-40. PubMed ID: 9763084
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis.
Mannweiler S; Amersdorfer P; Trajanoski S; Terrett JA; King D; Mehes G
Pathol Oncol Res; 2009 Jun; 15(2):167-72. PubMed ID: 18802790
[TBL] [Abstract][Full Text] [Related]
39. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.
Wright GL; Grob BM; Haley C; Grossman K; Newhall K; Petrylak D; Troyer J; Konchuba A; Schellhammer PF; Moriarty R
Urology; 1996 Aug; 48(2):326-34. PubMed ID: 8753752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
